NCT03210623 is a NA clinical trial of stent retriever(TonbridgeMT) in Ischemic Stroke, sponsored by Ton-Bridge Medical Tech. Co., Ltd.

Who is sponsoring NCT03210623?

NCT03210623 is sponsored by Ton-Bridge Medical Tech. Co., Ltd.

What drugs are being tested in NCT03210623?

Interventions in NCT03210623: stent retriever(TonbridgeMT), Solitaire™.

What condition does NCT03210623 study?

NCT03210623 studies Ischemic Stroke.

Is NCT03210623 still recruiting?

NCT03210623 is currently completed. Last updated 12 September 2018.

Last reviewed 2018-09-12 · How we verify

NCT03210623

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stent Retriever's(TonbridgeMT) Endovascular Therapy for Acute Ischemic Stroke(AIS)

Completed NA Last updated 12 September 2018

What this trial tests

NA trial testing stent retriever(TonbridgeMT) in Ischemic Stroke in 220 participants. Completed in 27 August 2018.

Timeline

3 August 2017

Primary endpoint
27 August 2018

27 August 2018

Quick facts

Lead sponsor	Ton-Bridge Medical Tech. Co., Ltd
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	220
Start date	3 August 2017
Primary completion	27 August 2018
Estimated completion	27 August 2018
Sites	17 locations across China

Drugs / interventions tested

stent retriever(TonbridgeMT)
Solitaire™

Conditions studied

Ischemic Stroke — all drugs for Ischemic Stroke →

Sponsor

Ton-Bridge Medical Tech. Co., Ltd

Who can join

Adults 18 to 80, any sex, with Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a prospective, multi-center, stratified randomized, single-blind, parallel assignment, active control, non-inferiority trial. Patients are randomized 1 : 1 to either stent retriever(TonbridgeMT) or Solitaire™ for endovascular therapy for AIS. The study aims to evaluate the benefit and safety of stent retriever(TonbridgeMT) for AIS therapy, as compared to Solitaire™.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Efficacy and Safety of a Novel Thrombectomy Device in Patients With Acute Ischemic Stroke: A Randomized Controlled Trial.
Zhang Y, Hua W, Li Z, Peng Y, et al · · 2021 · cited 7× · PMID 34456847 · DOI 10.3389/fneur.2021.686253
Benefits of first-pass reperfusion: secondary analysis based on three randomized multicenter trials in China.
Cao J, Yang Z, Zhu Y, Ke K, et al · · 2025 · PMID 40773266 · DOI 10.1097/js9.0000000000003128

Verify or expand the search:

Other recruiting trials for Ischemic Stroke

Currently open trials in the same condition.

NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting

Other Ton-Bridge Medical Tech. Co., Ltd trials

Trials by the same sponsor.

NCT05822804 — Safety and Efficacy of the Vascular Closure Device (Tonbridge) in Hemostasis Treatment of Femoral Artery Puncture · NA · completed
NCT05755516 — Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial Aneu · NA · completed
NCT05119647 — A Single-Arm Objective Performance Criteria Trial for Intracranial Thrombus Aspiration Catheter · NA · completed
NCT04799964 — Efficacy and Safety of the Flow Diverter (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms · NA · completed
NCT04918420 — A Single-arm Trial of the Flow Diverter (Tonbridge) For Endovascular Treatment of Intracranial Aneurysms · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03210623 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ton-Bridge Medical Tech. Co., Ltd
Last refreshed: 12 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03210623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing